| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | RNA polymerase II cis-regulatory region sequence-specific DNA binding | ZNF419 MYCL ZNF8 HINFP ZNF250 ZNF717 ZNF17 ZNF776 ZNF146 HDAC5 ZNF154 HDAC4 ZNF175 GLI2 GLI3 ZNF423 ZNF587 ZNF780B ZNF256 ZFP14 ZNF683 ZFHX3 ZNF528 RREB1 ZNF467 ZNF417 ZNF471 TET3 ZNF548 ZFP82 ZNF710 ZNF461 | 3.36e-18 | 1244 | 81 | 32 | GO:0000978 |
| GeneOntologyMolecularFunction | RNA polymerase II transcription regulatory region sequence-specific DNA binding | ZNF419 MYCL ZNF8 HINFP ZNF250 ZNF717 ZNF17 ZNF776 ZNF146 HDAC5 ZNF154 HDAC4 ZNF175 GLI2 GLI3 ZNF423 ZNF587 ZNF780B ZNF256 ZFP14 ZNF683 ZFHX3 ZNF749 ZNF528 RREB1 ZNF467 ZNF417 ZNF471 TET3 ZNF548 ZFP82 ZNF518A ZNF710 ZNF461 | 4.19e-18 | 1459 | 81 | 34 | GO:0000977 |
| GeneOntologyMolecularFunction | cis-regulatory region sequence-specific DNA binding | ZNF419 MYCL ZNF8 HINFP ZNF250 ZNF717 ZNF17 ZNF776 ZNF146 HDAC5 ZNF154 HDAC4 ZNF175 GLI2 GLI3 ZNF423 ZNF587 ZNF780B ZNF256 ZFP14 ZNF683 ZFHX3 ZNF528 RREB1 ZNF467 ZNF417 ZNF471 TET3 ZNF548 ZFP82 ZNF710 ZNF461 | 6.29e-18 | 1271 | 81 | 32 | GO:0000987 |
| GeneOntologyMolecularFunction | DNA-binding transcription factor activity, RNA polymerase II-specific | ZNF419 MYCL ZNF8 HINFP ZNF250 ZNF717 ZNF17 ZNF776 ZNF146 HDAC5 ZNF154 ZNF175 GLI2 GLI3 ZNF423 ZNF587 ZNF780B ZNF256 ZFP14 ZFHX3 ZNF749 ZNF528 RREB1 ZNF467 ZNF417 ZNF471 ZNF548 ZFP82 ZNF518A ZNF461 | 9.38e-15 | 1412 | 81 | 30 | GO:0000981 |
| GeneOntologyBiologicalProcess | smoothened signaling pathway involved in ventral spinal cord interneuron specification | 4.56e-05 | 3 | 81 | 2 | GO:0021775 | |
| GeneOntologyBiologicalProcess | smoothened signaling pathway involved in spinal cord motor neuron cell fate specification | 4.56e-05 | 3 | 81 | 2 | GO:0021776 | |
| GeneOntologyBiologicalProcess | smoothened signaling pathway involved in ventral spinal cord patterning | 4.56e-05 | 3 | 81 | 2 | GO:0021910 | |
| GeneOntologyBiologicalProcess | osteoblast development | 5.40e-05 | 19 | 81 | 3 | GO:0002076 | |
| GeneOntologyCellularComponent | GLI-SUFU complex | 8.85e-05 | 4 | 81 | 2 | GO:1990788 | |
| GeneOntologyCellularComponent | transcription repressor complex | 3.65e-04 | 87 | 81 | 4 | GO:0017053 | |
| MousePheno | abnormal brain ventricular system morphology | 9.04e-06 | 393 | 50 | 9 | MP:0002200 | |
| MousePheno | abnormal thalamus morphology | 4.01e-05 | 54 | 50 | 4 | MP:0000832 | |
| MousePheno | reduced cerebellar foliation | 4.70e-05 | 20 | 50 | 3 | MP:0009719 | |
| MousePheno | enlarged cerebral aqueduct | 7.49e-05 | 4 | 50 | 2 | MP:0031442 | |
| MousePheno | premature lambdoid suture closure | 7.49e-05 | 4 | 50 | 2 | MP:0030356 | |
| MousePheno | acoria | 7.49e-05 | 4 | 50 | 2 | MP:0012101 | |
| MousePheno | lethality throughout fetal growth and development, incomplete penetrance | 9.30e-05 | 208 | 50 | 6 | MP:0011109 | |
| MousePheno | abnormal right lung accessory lobe morphology | 1.25e-04 | 5 | 50 | 2 | MP:0009571 | |
| MousePheno | lethality throughout fetal growth and development | 1.40e-04 | 435 | 50 | 8 | MP:0006208 | |
| MousePheno | exencephaly | 1.61e-04 | 230 | 50 | 6 | MP:0000914 | |
| MousePheno | enlarged lateral ventricles | 2.26e-04 | 84 | 50 | 4 | MP:0008535 | |
| MousePheno | abnormal ear shape | 2.60e-04 | 7 | 50 | 2 | MP:0000022 | |
| MousePheno | abnormal lateral ventricle morphology | 2.89e-04 | 164 | 50 | 5 | MP:0000823 | |
| MousePheno | abnormal cerebellum development | 3.78e-04 | 96 | 50 | 4 | MP:0000854 | |
| Domain | Znf_C2H2/integrase_DNA-bd | ZNF419 ZNF8 HINFP ZNF250 ZNF17 ZNF776 ZNF146 ZNF154 ZNF175 GLI2 GLI3 ZNF423 ZNF587 ZNF780B ZNF256 ZIM2 ZFP14 ZNF683 ZFHX3 ZNF749 ZNF528 ZNF230 RREB1 ZNF467 CHAMP1 ZNF417 ZNF471 ZNF548 ZFP82 ZNF518A ZNF710 ZNF461 | 2.19e-25 | 694 | 79 | 32 | IPR013087 |
| Domain | - | ZNF419 ZNF8 HINFP ZNF250 ZNF17 ZNF776 ZNF146 ZNF154 ZNF175 GLI2 GLI3 ZNF423 ZNF587 ZNF780B ZNF256 ZIM2 ZFP14 ZNF683 ZFHX3 ZNF749 ZNF528 ZNF230 RREB1 ZNF467 CHAMP1 ZNF417 ZNF471 ZNF548 ZFP82 ZNF710 ZNF461 | 2.06e-24 | 679 | 79 | 31 | 3.30.160.60 |
| Domain | zf-C2H2 | ZNF419 ZNF8 HINFP ZNF250 ZNF17 ZNF776 ZNF146 ZNF154 ZNF175 GLI2 ZNF423 ZNF587 ZNF780B ZNF256 ZIM2 ZFP14 ZNF683 ZFHX3 ZNF749 ZNF528 ZNF230 RREB1 ZNF467 CHAMP1 ZNF417 ZNF471 ZNF548 ZFP82 ZNF518A ZNF710 ZNF461 | 3.80e-24 | 693 | 79 | 31 | PF00096 |
| Domain | ZINC_FINGER_C2H2_2 | ZNF419 ZNF8 HINFP ZNF250 ZNF17 ZNF776 ZNF146 ZNF154 ZNF175 GLI2 GLI3 ZNF423 ZNF587 ZNF780B ZNF256 ZIM2 ZFP14 ZNF683 ZFHX3 ZNF749 ZNF528 ZNF230 RREB1 ZNF467 CHAMP1 ZNF417 ZNF471 ZNF548 ZFP82 ZNF518A ZNF710 ZNF461 | 6.60e-24 | 775 | 79 | 32 | PS50157 |
| Domain | ZINC_FINGER_C2H2_1 | ZNF419 ZNF8 HINFP ZNF250 ZNF17 ZNF776 ZNF146 ZNF154 ZNF175 GLI2 GLI3 ZNF423 ZNF587 ZNF780B ZNF256 ZIM2 ZFP14 ZNF683 ZFHX3 ZNF749 ZNF528 ZNF230 RREB1 ZNF467 CHAMP1 ZNF417 ZNF471 ZNF548 ZFP82 ZNF518A ZNF710 ZNF461 | 7.15e-24 | 777 | 79 | 32 | PS00028 |
| Domain | Znf_C2H2-like | ZNF419 ZNF8 HINFP ZNF250 ZNF17 ZNF776 ZNF146 ZNF154 ZNF175 GLI2 GLI3 ZNF423 ZNF587 ZNF780B ZNF256 ZIM2 ZFP14 ZNF683 ZFHX3 ZNF749 ZNF528 ZNF230 RREB1 ZNF467 CHAMP1 ZNF417 ZNF471 ZNF548 ZFP82 ZNF518A ZNF710 ZNF461 | 1.50e-23 | 796 | 79 | 32 | IPR015880 |
| Domain | Znf_C2H2 | ZNF419 ZNF8 HINFP ZNF250 ZNF17 ZNF776 ZNF146 ZNF154 ZNF175 GLI2 GLI3 ZNF423 ZNF587 ZNF780B ZNF256 ZIM2 ZFP14 ZNF683 ZFHX3 ZNF749 ZNF528 ZNF230 RREB1 ZNF467 CHAMP1 ZNF417 ZNF471 ZNF548 ZFP82 ZNF518A ZNF710 ZNF461 | 2.11e-23 | 805 | 79 | 32 | IPR007087 |
| Domain | ZnF_C2H2 | ZNF419 ZNF8 HINFP ZNF250 ZNF17 ZNF776 ZNF146 ZNF154 ZNF175 GLI2 GLI3 ZNF423 ZNF587 ZNF780B ZNF256 ZIM2 ZFP14 ZNF683 ZFHX3 ZNF749 ZNF528 ZNF230 RREB1 ZNF467 CHAMP1 ZNF417 ZNF471 ZNF548 ZFP82 ZNF518A ZNF710 ZNF461 | 2.37e-23 | 808 | 79 | 32 | SM00355 |
| Domain | KRAB | ZNF419 ZNF8 ZNF250 ZNF17 ZNF776 ZNF154 ZNF175 ZNF587 ZNF780B ZNF256 ZIM2 ZFP14 ZNF749 ZNF528 ZNF230 ZNF417 ZNF471 ZNF548 ZFP82 ZNF461 | 2.50e-17 | 358 | 79 | 20 | PS50805 |
| Domain | KRAB | ZNF419 ZNF8 ZNF250 ZNF17 ZNF776 ZNF154 ZNF175 ZNF587 ZNF780B ZNF256 ZIM2 ZFP14 ZNF749 ZNF528 ZNF230 ZNF417 ZNF471 ZNF548 ZFP82 ZNF461 | 2.50e-17 | 358 | 79 | 20 | PF01352 |
| Domain | KRAB | ZNF419 ZNF8 ZNF250 ZNF17 ZNF776 ZNF154 ZNF175 ZNF587 ZNF780B ZNF256 ZIM2 ZFP14 ZNF749 ZNF528 ZNF230 ZNF417 ZNF471 ZNF548 ZFP82 ZNF461 | 4.51e-17 | 369 | 79 | 20 | SM00349 |
| Domain | KRAB | ZNF419 ZNF8 ZNF250 ZNF17 ZNF776 ZNF154 ZNF175 ZNF587 ZNF780B ZNF256 ZIM2 ZFP14 ZNF749 ZNF528 ZNF230 ZNF417 ZNF471 ZNF548 ZFP82 ZNF461 | 4.75e-17 | 370 | 79 | 20 | IPR001909 |
| Domain | zf-C2H2_6 | ZNF419 ZNF8 ZNF250 ZNF17 ZNF154 ZNF423 ZNF587 ZNF780B ZNF256 ZFP14 ZNF749 RREB1 ZNF467 ZNF417 ZNF548 ZFP82 ZNF710 ZNF461 | 7.72e-16 | 314 | 79 | 18 | PF13912 |
| Domain | Hist_deacetylase_Gln_rich_N | 5.29e-05 | 3 | 79 | 2 | IPR024643 | |
| Domain | HDAC4_Gln | 5.29e-05 | 3 | 79 | 2 | PF12203 | |
| Domain | Histone_deAcase_II_euk | 1.05e-04 | 4 | 79 | 2 | IPR017320 | |
| Domain | DUF3398 | 2.62e-04 | 6 | 79 | 2 | PF11878 | |
| Domain | DOCK_C/D_N | 2.62e-04 | 6 | 79 | 2 | IPR021816 | |
| Domain | Hist_deacetyl | 9.48e-04 | 11 | 79 | 2 | PF00850 | |
| Domain | His_deacetylse_dom | 9.48e-04 | 11 | 79 | 2 | IPR023801 | |
| Domain | DOCK_C | 9.48e-04 | 11 | 79 | 2 | IPR010703 | |
| Domain | DHR-1_domain | 9.48e-04 | 11 | 79 | 2 | IPR027007 | |
| Domain | DHR_2 | 9.48e-04 | 11 | 79 | 2 | PS51651 | |
| Domain | DHR_1 | 9.48e-04 | 11 | 79 | 2 | PS51650 | |
| Domain | DOCK-C2 | 9.48e-04 | 11 | 79 | 2 | PF14429 | |
| Domain | DHR-2 | 9.48e-04 | 11 | 79 | 2 | IPR027357 | |
| Domain | DHR-2 | 9.48e-04 | 11 | 79 | 2 | PF06920 | |
| Domain | - | 9.48e-04 | 11 | 79 | 2 | 3.40.800.20 | |
| Domain | His_deacetylse | 9.48e-04 | 11 | 79 | 2 | IPR000286 | |
| Domain | DOCK | 9.48e-04 | 11 | 79 | 2 | IPR026791 | |
| Domain | CRAL_TRIO | 3.52e-03 | 21 | 79 | 2 | PF00650 | |
| Domain | Pentatricopeptide_repeat | 4.22e-03 | 23 | 79 | 2 | IPR002885 | |
| Domain | - | 4.22e-03 | 23 | 79 | 2 | 3.40.525.10 | |
| Domain | Spectrin | 4.22e-03 | 23 | 79 | 2 | PF00435 | |
| Domain | SEC14 | 4.98e-03 | 25 | 79 | 2 | SM00516 | |
| Domain | CRAL_TRIO | 5.79e-03 | 27 | 79 | 2 | PS50191 | |
| Domain | CRAL-TRIO_dom | 6.22e-03 | 28 | 79 | 2 | IPR001251 | |
| Domain | Spectrin_repeat | 6.66e-03 | 29 | 79 | 2 | IPR002017 | |
| Domain | Spectrin/alpha-actinin | 8.07e-03 | 32 | 79 | 2 | IPR018159 | |
| Domain | SPEC | 8.07e-03 | 32 | 79 | 2 | SM00150 | |
| Pathway | REACTOME_RNA_POLYMERASE_II_TRANSCRIPTION | ZNF419 ZNF250 ZNF717 ZNF17 ZNF776 PLK2 HDAC5 ZNF154 HDAC4 ZNF175 GLI2 GLI3 CAMK2G ZNF587 ZNF256 ZIM2 ZFP14 ZFHX3 ZNF749 ZNF528 ZNF230 ZNF417 ZNF471 ZNF548 HTT SOD2 ZNF710 ZNF461 | 4.37e-14 | 1387 | 57 | 28 | M734 |
| Pathway | REACTOME_RUNX2_REGULATES_CHONDROCYTE_MATURATION | 1.59e-04 | 5 | 57 | 2 | M27804 | |
| Pathway | REACTOME_RUNX2_REGULATES_BONE_DEVELOPMENT | 2.60e-04 | 31 | 57 | 3 | M27805 | |
| Pathway | REACTOME_GLI_PROTEINS_BIND_PROMOTERS_OF_HH_RESPONSIVE_GENES_TO_PROMOTE_TRANSCRIPTION | 3.33e-04 | 7 | 57 | 2 | M27501 | |
| Pubmed | 4.33e-10 | 181 | 81 | 9 | 37372979 | ||
| Pubmed | The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery. | ZNF250 PLK2 ZNF146 WASHC4 RBM27 GLI2 GLI3 CAMK2G AHCTF1 SLC39A10 ZNF467 CHAMP1 ZNF417 PLOD1 ZFP82 SOD2 ZNF518A | 2.07e-09 | 1203 | 81 | 17 | 29180619 |
| Pubmed | 2.68e-08 | 14 | 81 | 4 | 22549777 | ||
| Pubmed | TTC7A ZNF8 WAPL ZNF146 GLI3 AHCTF1 POLRMT RNF213 MACF1 ZFHX3 RREB1 CHAMP1 ZFP82 ZNF518A ZNF461 | 4.03e-08 | 1116 | 81 | 15 | 31753913 | |
| Pubmed | 3.44e-07 | 284 | 81 | 8 | 15057824 | ||
| Pubmed | 5.84e-07 | 418 | 81 | 9 | 34709266 | ||
| Pubmed | The role of sonic hedgehog-Gli2 pathway in the masculinization of external genitalia. | 1.98e-06 | 11 | 81 | 3 | 21586556 | |
| Pubmed | 5.01e-06 | 407 | 81 | 8 | 12693553 | ||
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 29472387 | ||
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 27626651 | ||
| Pubmed | Normal exon copy number of the GLI2 and GLI3 genes in patients with esophageal atresia. | 5.36e-06 | 2 | 81 | 2 | 23442119 | |
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 17283082 | ||
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 17975112 | ||
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 10693670 | ||
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 23364788 | ||
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 31375688 | ||
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 22403301 | ||
| Pubmed | Adult Gli2+/-;Gli3Δ699/+ Male and Female Mice Display a Spectrum of Genital Malformation. | 5.36e-06 | 2 | 81 | 2 | 27814383 | |
| Pubmed | Differential effects of GLI2 and GLI3 in regulating cervical cancer malignancy in vitro and in vivo. | 5.36e-06 | 2 | 81 | 2 | 29967343 | |
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 20154143 | ||
| Pubmed | Control of cardiac growth by histone acetylation/deacetylation. | 5.36e-06 | 2 | 81 | 2 | 16397154 | |
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 24302884 | ||
| Pubmed | A study on etiology of incontinence in double knockout mouse model. | 5.36e-06 | 2 | 81 | 2 | 36272934 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | HDAC4 TRIO GLI2 ZNF587 RNF213 MACF1 ZFHX3 CTBP2 ZNF528 PLOD1 TET3 DNAH14 HTT ZNF461 | 8.11e-06 | 1489 | 81 | 14 | 28611215 |
| Pubmed | A census of human transcription factors: function, expression and evolution. | MYCL HINFP ZNF146 ZNF175 GLI2 GLI3 AHCTF1 ZFHX3 ZNFX1 ZNF230 RREB1 | 8.29e-06 | 908 | 81 | 11 | 19274049 |
| Pubmed | Murine models of VACTERL syndrome: Role of sonic hedgehog signaling pathway. | 1.60e-05 | 3 | 81 | 2 | 11172440 | |
| Pubmed | 1.60e-05 | 3 | 81 | 2 | 26010061 | ||
| Pubmed | 1.60e-05 | 3 | 81 | 2 | 8387379 | ||
| Pubmed | Roles of the DOCK-D family proteins in a mouse model of neuroinflammation. | 1.60e-05 | 3 | 81 | 2 | 32241915 | |
| Pubmed | Positive regulation of Hedgehog signaling via phosphorylation of GLI2/GLI3 by DYRK2 kinase. | 1.60e-05 | 3 | 81 | 2 | 38968120 | |
| Pubmed | Blocking the association of HDAC4 with MAP1S accelerates autophagy clearance of mutant Huntingtin. | 1.60e-05 | 3 | 81 | 2 | 26540094 | |
| Pubmed | Unique and complimentary activities of the Gli transcription factors in Hedgehog signaling. | 1.60e-05 | 3 | 81 | 2 | 16571352 | |
| Pubmed | 1.60e-05 | 3 | 81 | 2 | 22648949 | ||
| Pubmed | Different expression patterns of Gli1-3 in mouse embryonic maxillofacial development. | 1.60e-05 | 3 | 81 | 2 | 22178118 | |
| Pubmed | Identification of a signal-responsive nuclear export sequence in class II histone deacetylases. | 1.60e-05 | 3 | 81 | 2 | 11509672 | |
| Pubmed | 1.60e-05 | 3 | 81 | 2 | 16221676 | ||
| Pubmed | Neddylation Regulates Class IIa and III Histone Deacetylases to Mediate Myoblast Differentiation. | 1.60e-05 | 3 | 81 | 2 | 34502418 | |
| Pubmed | Histone deacetylase 5 is a phosphorylation substrate of protein kinase D in osteoclasts. | 1.60e-05 | 3 | 81 | 2 | 35318161 | |
| Pubmed | 1.60e-05 | 3 | 81 | 2 | 19955409 | ||
| Pubmed | 1.60e-05 | 3 | 81 | 2 | 23297420 | ||
| Pubmed | A FAK/HDAC5 signaling axis controls osteocyte mechanotransduction. | 1.60e-05 | 3 | 81 | 2 | 32612176 | |
| Pubmed | 1.60e-05 | 3 | 81 | 2 | 25489064 | ||
| Pubmed | Sonic hedgehog through Gli2 and Gli3 is required for the proper development of placental labyrinth. | 1.60e-05 | 3 | 81 | 2 | 25695606 | |
| Pubmed | Gli family members are differentially expressed during the mitotic phase of spermatogenesis. | 1.60e-05 | 3 | 81 | 2 | 9178901 | |
| Pubmed | Crystal structure of a five-finger GLI-DNA complex: new perspectives on zinc fingers. | 1.60e-05 | 3 | 81 | 2 | 8378770 | |
| Pubmed | 2.38e-05 | 24 | 81 | 3 | 32497091 | ||
| Pubmed | 2.84e-05 | 151 | 81 | 5 | 17043677 | ||
| Pubmed | 3.20e-05 | 4 | 81 | 2 | 9027508 | ||
| Pubmed | 3.20e-05 | 4 | 81 | 2 | 17949687 | ||
| Pubmed | 3.20e-05 | 4 | 81 | 2 | 22281533 | ||
| Pubmed | 3.20e-05 | 4 | 81 | 2 | 9006072 | ||
| Pubmed | 3.20e-05 | 4 | 81 | 2 | 27793025 | ||
| Pubmed | 3.20e-05 | 4 | 81 | 2 | 28688716 | ||
| Pubmed | 3.20e-05 | 4 | 81 | 2 | 29429990 | ||
| Pubmed | Expression profile of Gli family members and Shh in normal and mutant mouse limb development. | 3.20e-05 | 4 | 81 | 2 | 9438426 | |
| Pubmed | 3.20e-05 | 4 | 81 | 2 | 8150204 | ||
| Pubmed | 3.20e-05 | 4 | 81 | 2 | 29886060 | ||
| Pubmed | SIK1 is a class II HDAC kinase that promotes survival of skeletal myocytes. | 3.20e-05 | 4 | 81 | 2 | 17468767 | |
| Pubmed | 3.20e-05 | 4 | 81 | 2 | 18187866 | ||
| Pubmed | 3.20e-05 | 4 | 81 | 2 | 24952464 | ||
| Pubmed | PTHrP targets HDAC4 and HDAC5 to repress chondrocyte hypertrophy. | 3.20e-05 | 4 | 81 | 2 | 30843886 | |
| Pubmed | 3.20e-05 | 4 | 81 | 2 | 27759007 | ||
| Pubmed | Class IIa histone deacetylases: conducting development and differentiation. | 3.20e-05 | 4 | 81 | 2 | 19412888 | |
| Pubmed | mHDA1/HDAC5 histone deacetylase interacts with and represses MEF2A transcriptional activity. | 3.20e-05 | 4 | 81 | 2 | 10748098 | |
| Pubmed | Anorectal malformations caused by defects in sonic hedgehog signaling. | 3.20e-05 | 4 | 81 | 2 | 11485934 | |
| Pubmed | Class II HDACs mediate CaMK-dependent signaling to NRSF in ventricular myocytes. | 3.20e-05 | 4 | 81 | 2 | 17011572 | |
| Pubmed | HDAC4 and 5 repression of TBX5 is relieved by protein kinase D1. | 3.20e-05 | 4 | 81 | 2 | 31784580 | |
| Pubmed | 3.20e-05 | 4 | 81 | 2 | 20956384 | ||
| Pubmed | 3.20e-05 | 4 | 81 | 2 | 10531011 | ||
| Pubmed | Ankyrin repeats of ANKRA2 recognize a PxLPxL motif on the 3M syndrome protein CCDC8. | 3.82e-05 | 28 | 81 | 3 | 25752541 | |
| Pubmed | MRAP deficiency impairs adrenal progenitor cell differentiation and gland zonation. | 3.82e-05 | 28 | 81 | 3 | 29879378 | |
| Pubmed | 4.08e-05 | 709 | 81 | 9 | 22988430 | ||
| Pubmed | 4.36e-05 | 83 | 81 | 4 | 20562864 | ||
| Pubmed | 5.33e-05 | 5 | 81 | 2 | 10983972 | ||
| Pubmed | SUMOylation by Pias1 regulates the activity of the Hedgehog dependent Gli transcription factors. | 5.33e-05 | 5 | 81 | 2 | 20711444 | |
| Pubmed | Functional compensation in Hedgehog signaling during mouse prostate development. | 5.33e-05 | 5 | 81 | 2 | 16707121 | |
| Pubmed | 5.33e-05 | 5 | 81 | 2 | 9118802 | ||
| Pubmed | 5.33e-05 | 5 | 81 | 2 | 15194749 | ||
| Pubmed | Evidence for the involvement of the Gli gene family in embryonic mouse lung development. | 5.33e-05 | 5 | 81 | 2 | 9268579 | |
| Pubmed | A novel corepressor, BCoR-L1, represses transcription through an interaction with CtBP. | 5.33e-05 | 5 | 81 | 2 | 17379597 | |
| Pubmed | 5.33e-05 | 5 | 81 | 2 | 18218981 | ||
| Pubmed | Regulation of MEF2 by histone deacetylase 4- and SIRT1 deacetylase-mediated lysine modifications. | 5.33e-05 | 5 | 81 | 2 | 16166628 | |
| Pubmed | 5.33e-05 | 5 | 81 | 2 | 23624624 | ||
| Pubmed | 5.33e-05 | 5 | 81 | 2 | 24218555 | ||
| Pubmed | Gli regulation by the opposing activities of fused and suppressor of fused. | 5.33e-05 | 5 | 81 | 2 | 10806483 | |
| Pubmed | 5.33e-05 | 5 | 81 | 2 | 26282181 | ||
| Pubmed | Gli1 is a target of Sonic hedgehog that induces ventral neural tube development. | 5.33e-05 | 5 | 81 | 2 | 9216996 | |
| Pubmed | HDAC4 integrates PTH and sympathetic signaling in osteoblasts. | 5.33e-05 | 5 | 81 | 2 | 24934156 | |
| Pubmed | CaM kinase II selectively signals to histone deacetylase 4 during cardiomyocyte hypertrophy. | 5.33e-05 | 5 | 81 | 2 | 16767219 | |
| Pubmed | 5.33e-05 | 5 | 81 | 2 | 15614767 | ||
| Pubmed | 5.33e-05 | 5 | 81 | 2 | 19996099 | ||
| Pubmed | 5.33e-05 | 5 | 81 | 2 | 15710388 | ||
| Pubmed | 5.33e-05 | 5 | 81 | 2 | 19071119 | ||
| Pubmed | 5.33e-05 | 5 | 81 | 2 | 17328886 | ||
| Pubmed | 5.33e-05 | 5 | 81 | 2 | 19893013 | ||
| Pubmed | 5.33e-05 | 5 | 81 | 2 | 16611981 | ||
| Pubmed | 5.33e-05 | 5 | 81 | 2 | 15315762 | ||
| Pubmed | 5.33e-05 | 5 | 81 | 2 | 11114197 | ||
| Pubmed | 5.33e-05 | 5 | 81 | 2 | 10564661 | ||
| Pubmed | 5.33e-05 | 5 | 81 | 2 | 21282606 | ||
| Interaction | ZNF287 interactions | 3.87e-09 | 60 | 80 | 7 | int:ZNF287 | |
| Interaction | ZFP37 interactions | 3.95e-08 | 49 | 80 | 6 | int:ZFP37 | |
| Interaction | ZNF667 interactions | 6.40e-08 | 53 | 80 | 6 | int:ZNF667 | |
| Interaction | ZNF423 interactions | 4.45e-07 | 73 | 80 | 6 | int:ZNF423 | |
| Interaction | TRIM28 interactions | ZNF419 ZNF8 ZNF250 ZNF17 ZNF776 WASHC4 HDAC5 HDAC4 ZNF587 ZNF256 FES POLRMT ZIM2 ZNF749 CHAMP1 ZNF417 ZNF471 ZFP82 ZNF518A VCPIP1 | 8.53e-07 | 1474 | 80 | 20 | int:TRIM28 |
| Interaction | ZFP62 interactions | 2.70e-06 | 99 | 80 | 6 | int:ZFP62 | |
| Interaction | GLI2 interactions | 2.70e-06 | 99 | 80 | 6 | int:GLI2 | |
| Interaction | TRIM39 interactions | 4.49e-06 | 108 | 80 | 6 | int:TRIM39 | |
| Interaction | ZNF710 interactions | 5.83e-06 | 30 | 80 | 4 | int:ZNF710 | |
| Interaction | CCDC125 interactions | 6.92e-06 | 67 | 80 | 5 | int:CCDC125 | |
| Interaction | MYNN interactions | 7.61e-06 | 32 | 80 | 4 | int:MYNN | |
| Interaction | RNF4 interactions | ZNF250 PLK2 ZNF146 WASHC4 RBM27 GLI2 GLI3 CAMK2G AHCTF1 SLC39A10 ZNF467 CHAMP1 ZNF417 PLOD1 ZFP82 HTT SOD2 ZNF518A | 8.11e-06 | 1412 | 80 | 18 | int:RNF4 |
| Interaction | ZNF8 interactions | 8.59e-06 | 70 | 80 | 5 | int:ZNF8 | |
| Interaction | ZBTB17 interactions | 1.37e-05 | 77 | 80 | 5 | int:ZBTB17 | |
| Interaction | MTUS2 interactions | 1.58e-05 | 370 | 80 | 9 | int:MTUS2 | |
| Interaction | PRDM5 interactions | 1.65e-05 | 80 | 80 | 5 | int:PRDM5 | |
| Interaction | GOLGA6L9 interactions | 2.41e-05 | 216 | 80 | 7 | int:GOLGA6L9 | |
| Interaction | ZNF768 interactions | 3.05e-05 | 151 | 80 | 6 | int:ZNF768 | |
| Interaction | ZNF547 interactions | 3.93e-05 | 17 | 80 | 3 | int:ZNF547 | |
| Interaction | CBX3 interactions | ZNF8 ZNF250 ZNF776 WAPL RBM27 AHCTF1 MACF1 RREB1 CHAMP1 ZFP82 ZNF518A | 4.74e-05 | 646 | 80 | 11 | int:CBX3 |
| Interaction | ZNF473 interactions | 7.23e-05 | 56 | 80 | 4 | int:ZNF473 | |
| Interaction | CEP70 interactions | 8.20e-05 | 262 | 80 | 7 | int:CEP70 | |
| Interaction | CBX5 interactions | 8.40e-05 | 356 | 80 | 8 | int:CBX5 | |
| Interaction | BEGAIN interactions | 8.88e-05 | 59 | 80 | 4 | int:BEGAIN | |
| Interaction | IKZF2 interactions | 1.47e-04 | 26 | 80 | 3 | int:IKZF2 | |
| Interaction | ZSCAN10 interactions | 1.47e-04 | 26 | 80 | 3 | int:ZSCAN10 | |
| Interaction | KRTAP10-7 interactions | 1.64e-04 | 293 | 80 | 7 | int:KRTAP10-7 | |
| Interaction | TTC23 interactions | 1.79e-04 | 208 | 80 | 6 | int:TTC23 | |
| Interaction | MYOCD interactions | 2.04e-04 | 29 | 80 | 3 | int:MYOCD | |
| Interaction | ZFP3 interactions | 2.26e-04 | 30 | 80 | 3 | int:ZFP3 | |
| Interaction | ZNF837 interactions | 2.76e-04 | 79 | 80 | 4 | int:ZNF837 | |
| Interaction | ZNF382 interactions | 3.02e-04 | 33 | 80 | 3 | int:ZNF382 | |
| Interaction | RBAK interactions | 3.04e-04 | 81 | 80 | 4 | int:RBAK | |
| Interaction | AHRR interactions | 3.23e-04 | 7 | 80 | 2 | int:AHRR | |
| Interaction | KRT40 interactions | 3.24e-04 | 434 | 80 | 8 | int:KRT40 | |
| Interaction | ZNF652 interactions | 3.60e-04 | 35 | 80 | 3 | int:ZNF652 | |
| Interaction | SMAD3 interactions | 3.95e-04 | 447 | 80 | 8 | int:SMAD3 | |
| Interaction | ZBTB48 interactions | 4.16e-04 | 158 | 80 | 5 | int:ZBTB48 | |
| Interaction | MYF5 interactions | 4.25e-04 | 37 | 80 | 3 | int:MYF5 | |
| Interaction | ZFP28 interactions | 4.25e-04 | 37 | 80 | 3 | int:ZFP28 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr19q13 | ZNF419 ZNF8 ZNF17 ZNF776 ZNF146 ZNF154 ZNF175 ZNF587 ZNF780B ZNF256 ZIM2 ZFP14 ZNF749 ZNF528 ZNF230 ZNF417 ZNF471 ZNF548 ZFP82 ZNF461 | 1.74e-14 | 1192 | 81 | 20 | chr19q13 |
| Cytoband | 19q13.43 | ZNF419 ZNF8 ZNF776 ZNF587 ZNF256 ZNF749 ZNF417 ZNF471 ZNF548 | 4.80e-14 | 87 | 81 | 9 | 19q13.43 |
| Cytoband | 19q13.4 | 1.22e-05 | 79 | 81 | 4 | 19q13.4 | |
| Cytoband | 19q13.12 | 2.89e-04 | 72 | 81 | 3 | 19q13.12 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | ZNF419 ZNF8 HINFP ZNF250 ZNF717 ZNF17 ZNF776 ZNF146 ZNF154 ZNF175 GLI2 GLI3 ZNF423 ZNF587 ZNF780B ZNF256 ZIM2 ZFP14 ZNF683 ZFHX3 ZNF749 ZNF528 ZNF230 RREB1 ZNF467 CHAMP1 ZNF417 ZNF471 ZNF548 ZFP82 ZNF518A ZNF710 ZNF461 | 7.92e-30 | 718 | 63 | 33 | 28 |
| GeneFamily | Histone deacetylases, class IIA | 7.14e-05 | 4 | 63 | 2 | 992 | |
| ToppCell | cellseq2-Endothelial-Endothelial_Vascular-Endothelial_large_blood_vessel-VEC|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.18e-06 | 189 | 80 | 6 | bccb3481ffed597c845fe860da658505316105b5 | |
| ToppCell | COVID-19-Mast_cells-Transitioning_MDM|COVID-19 / group, cell type (main and fine annotations) | 6.42e-06 | 145 | 80 | 5 | 5c5fed4620c4c312d1052b8acad910453f7e8fcc | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Myeloid-Granulocytic-Neutrophil-Neu_c2-CXCR4(low)|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.82e-06 | 151 | 80 | 5 | b698ddc74565d47892c09c3f16d78038da2dd5e7 | |
| ToppCell | Control-B_naive-1|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 8.88e-06 | 155 | 80 | 5 | 0a78d1cab2bdba2dc8a74cdf35b5a0192370c4b5 | |
| ToppCell | Severe-B_naive-1|Severe / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.00e-05 | 159 | 80 | 5 | 2881b054bbeb479221ee3c38bbd9b0815b123579 | |
| ToppCell | Children_(3_yrs)-Immune-enucleated_erythrocyte-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.31e-05 | 168 | 80 | 5 | 8f0c4dfad9f6fed9dcc31795abfe77758ceb46a1 | |
| ToppCell | metastatic_Brain-T/NK_cells-Exhausted_Tfh|T/NK_cells / Location, Cell class and cell subclass | 1.73e-05 | 178 | 80 | 5 | 9a3581a0158dfa5a1cc942f8c532afb5e38b272a | |
| ToppCell | BAL-Severe-Lymphocyte-B-B_cell|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.83e-05 | 180 | 80 | 5 | c3c72531af5b9f7a7416727fe609dab5180e03b6 | |
| ToppCell | BAL-Severe-Lymphocyte-B-B_cell-B_cell-B_activate-7|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.83e-05 | 180 | 80 | 5 | 9f4bbaf6435c23e3e552ae22be8ea7884314192d | |
| ToppCell | BAL-Severe-Lymphocyte-B-B_cell-B_cell|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.83e-05 | 180 | 80 | 5 | b465f2f8b0e9a2034a4f1272bb00c77439164dbf | |
| ToppCell | COVID-19_Mild-NK_activated|COVID-19_Mild / Disease condition and Cell class | 1.98e-05 | 183 | 80 | 5 | 22bd05135906d0ecc4ba8c2e0a666093d1bf3b8f | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 2.14e-05 | 186 | 80 | 5 | 03db813598b67b1e08f759758a1c2023396921fa | |
| ToppCell | Bronchus_Control_(B.)-Epithelial-TX-AT2-2|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 2.62e-05 | 194 | 80 | 5 | 5bfc26668fa8f109f2ebc0d5fd98ab5bd219e62c | |
| ToppCell | VE-NK|VE / Condition, Cell_class and T cell subcluster | 2.82e-05 | 197 | 80 | 5 | cae6ff8763501e7a5897b50188ac2640d65a47c0 | |
| ToppCell | VE-NK-|VE / Condition, Cell_class and T cell subcluster | 2.82e-05 | 197 | 80 | 5 | ee89b8521fb4faaed9e4d39f7171e45eccf38b00 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.03e-05 | 200 | 80 | 5 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| ToppCell | Severe-B_intermediate-1|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 4.80e-05 | 111 | 80 | 4 | 7021009545178fac1f19f3c429bfedb2f38b680d | |
| Disease | Intellectual Disability | 1.01e-04 | 447 | 71 | 7 | C3714756 | |
| Disease | PULMONARY HYPERTENSION, PRIMARY, DEXFENFLURAMINE-ASSOCIATED | 1.19e-04 | 7 | 71 | 2 | C1969342 | |
| Disease | Pulmonary Hypertension, Primary, Fenfluramine-Associated | 1.19e-04 | 7 | 71 | 2 | C1969343 | |
| Disease | Pulmonary Hypertension, Primary, 1, With Hereditary Hemorrhagic Telangiectasia | 1.19e-04 | 7 | 71 | 2 | C3714844 | |
| Disease | Pulmonary Hypertension, Primary, 1 | 1.19e-04 | 7 | 71 | 2 | C4552070 | |
| Disease | Moyamoya disease | 1.24e-04 | 40 | 71 | 3 | MONDO_0016820 | |
| Disease | mean arterial pressure | 1.98e-04 | 499 | 71 | 7 | EFO_0006340 | |
| Disease | primary bacterial infectious disease (implicated_via_orthology) | 2.03e-04 | 9 | 71 | 2 | DOID:0050338 (implicated_via_orthology) | |
| Disease | cortical surface area measurement | TRPM6 GLI3 ZNF423 DOCK9 FES SLC4A10 MACF1 ZFHX3 CTBP2 RREB1 DENND3 | 3.51e-04 | 1345 | 71 | 11 | EFO_0010736 |
| Disease | brain measurement, neuroimaging measurement | 3.57e-04 | 550 | 71 | 7 | EFO_0004346, EFO_0004464 | |
| Disease | migraine disorder, type 2 diabetes mellitus | 4.14e-04 | 60 | 71 | 3 | MONDO_0005148, MONDO_0005277 | |
| Disease | Idiopathic pulmonary arterial hypertension | 6.70e-04 | 16 | 71 | 2 | C3203102 | |
| Disease | serum alanine aminotransferase measurement, response to combination chemotherapy | 6.79e-04 | 71 | 71 | 3 | EFO_0004735, EFO_0007965 | |
| Disease | Familial primary pulmonary hypertension | 7.58e-04 | 17 | 71 | 2 | C0340543 | |
| Disease | autosomal dominant intellectual developmental disorder (is_implicated_in) | 7.58e-04 | 17 | 71 | 2 | DOID:0060307 (is_implicated_in) | |
| Disease | neuroimaging measurement | 1.03e-03 | 1069 | 71 | 9 | EFO_0004346 | |
| Disease | Seizures | 1.91e-03 | 218 | 71 | 4 | C0036572 | |
| Disease | cortical surface area measurement, neuroimaging measurement | 2.21e-03 | 227 | 71 | 4 | EFO_0004346, EFO_0010736 | |
| Disease | Movement Disorders | 2.22e-03 | 29 | 71 | 2 | C0026650 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| KSVHHIFSVQENNHL | 401 | Q0P6H9 | |
| NEHNHHLINDFTIKQ | 246 | P56545 | |
| NITHHQLEKAIHNVL | 2806 | Q86UQ4 | |
| QSLQLHHELHAAHLL | 321 | A2RUS2 | |
| QHHHLPQHLHQQQVL | 701 | Q9P2N5 | |
| EKINSHHLHNNISHI | 841 | Q5JSJ4 | |
| LHHPHKSVQHVVLQA | 116 | P43378 | |
| HLEHNQLTKINFAHF | 211 | O43300 | |
| QLVHHINNDHIHGEK | 496 | P10071 | |
| SRQHEAQLHEHIKQQ | 101 | P56524 | |
| LLERHHIHTKNVEHI | 111 | Q4G0N4 | |
| VTHFTQAQINHHKIA | 771 | Q5SZK8 | |
| HHHHLLHQLVLNETQ | 71 | Q96KN4 | |
| QEQLVHHINNEHIHG | 451 | P10070 | |
| HHVLKNDVLAHQATV | 6266 | Q9UPN3 | |
| FIHNHEQHHKAQVEE | 321 | Q02809 | |
| QVYELTLHHTQHQDH | 356 | P42858 | |
| LHVHKFFHHCQLIQS | 826 | Q5JSL3 | |
| QLHEKHHLLLTFFHV | 721 | Q9BZ29 | |
| KGAVLHHLVNKHNVH | 721 | Q96JM3 | |
| HFHNRHVFQQQLIEK | 551 | Q8NCU4 | |
| TTHHLHEQHEAEIFQ | 71 | A2IDD5 | |
| THKVHLHHVQNFQKY | 71 | P05108 | |
| VAKHHQIHISEEQIA | 791 | Q0VDD8 | |
| ASVQNHEFLLVHHLQ | 946 | Q8WYP5 | |
| QHDHLTRQHEVQLQK | 101 | Q9UQL6 | |
| KFFEHVTQHLQQHLH | 31 | Q9BQA5 | |
| HNHHGENKTVLRKHN | 626 | Q9ULF5 | |
| LAHHLLVVHHGQRQK | 241 | O00411 | |
| AARHQLHQLHQLHQL | 106 | Q5T953 | |
| LESVNHIHQHDIVHR | 121 | Q13555 | |
| AFSQKSHHIRHQKIH | 276 | Q15072 | |
| RAAQLHHQHHHQLLL | 191 | P07332 | |
| VQTLLQNHKHHDKFT | 141 | Q3SY17 | |
| CHIQLHSHQFRQIHL | 21 | O75570 | |
| EQIKEYHHLHQAVHA | 1341 | Q63HN8 | |
| YHHLHQAVHAAKVIL | 1346 | Q63HN8 | |
| ESNNLVIHSVVKHFH | 101 | Q96I15 | |
| AFVQHSHLIQHQRVH | 431 | P15622 | |
| AFLTQAHLVGHQKIH | 491 | O43361 | |
| TNTLLHHLVQDVKQH | 486 | Q9BX84 | |
| KHFHISIHQQQHNYA | 201 | P12524 | |
| IHHILKQHLHVPEQD | 806 | Q92766 | |
| HFADHQETHHKQKLN | 106 | Q96SQ5 | |
| AYLHQHQKQHVGQKH | 131 | Q9Y2P7 | |
| HRVHEALMKQHHHQN | 211 | Q6U841 | |
| HFADHQETHHKQKLN | 106 | Q8TAU3 | |
| EFSQIHHLKQHSLTH | 471 | Q8N1W2 | |
| NFHEEHEKNSHHIHK | 171 | Q7Z5K2 | |
| HINAQIMQLHHSKHH | 41 | P04179 | |
| TFVQHIHRHNEIHYK | 221 | Q6AHZ1 | |
| HQKAQTALQQHLHHK | 521 | O43151 | |
| HALRENLKQHFQQHL | 236 | Q96JH7 | |
| AFSLHTQLNHHKNIH | 621 | Q9Y6R6 | |
| VHTIQEFVHHDENHS | 131 | Q9HB20 | |
| KSHQNQHEAHFVVEL | 1126 | Q9P2E3 | |
| FLQNVHLLQHLKAHE | 421 | Q9NZV7 | |
| RHHEHLTQHHKIQTL | 191 | Q9BY31 | |
| RQHSHLTHHLKIHNV | 516 | Q8N141 | |
| FKQSEHLIQHQRIHT | 271 | Q9BX82 | |
| FNHNAHLTVHKRIHT | 266 | P17098 | |
| QHLQHQALHSISVAK | 506 | Q2M389 | |
| FIHDFQLQKHQIIHT | 261 | Q9UIE0 | |
| HLVHHQKIHSEERLV | 491 | Q8NEK5 | |
| FNQIAHLVRHQKIHT | 306 | Q3MIS6 | |
| FSAQKHHQHALDVVN | 576 | Q9ULT0 | |
| AFRQHSHLTQHQKIH | 516 | Q9HCL3 | |
| HHQKQHLGEKHFRSN | 56 | Q13106 | |
| LAHIHQAHANQKHKC | 311 | Q2M1K9 | |
| IELHRILHHKHVVQF | 131 | Q9NYY3 | |
| HQLEHLHQIFVTKNH | 1141 | O15050 | |
| QHIHLEHHQRQQVAY | 2776 | O15050 | |
| FILHRHKQQVQHIHG | 206 | Q9BXE9 | |
| FRHNSTLVQHHKIHT | 296 | Q96HQ0 | |
| EHSIVQKHHQEEIIH | 66 | Q8NFP0 | |
| HQHTLFEHQKIHTEE | 201 | P17021 | |
| HKQHLVRHQRVHQTA | 311 | Q7Z7K2 | |
| QKSFTQLAHLQKHHL | 356 | Q8IZ20 | |
| QLAHLQKHHLVHTGE | 361 | Q8IZ20 | |
| HVLDVIHEVLHHQRQ | 536 | O75962 | |
| HSHLIQHQRIHTGEK | 481 | Q8TAF7 | |
| SHLNIHQKIHTGERH | 516 | Q9Y473 | |
| LNNKIHLQLHLTHLH | 1261 | Q15911 | |
| FHQKGSLIQHQQIHS | 441 | Q68DI1 |